Kenneth S. Suslick
Kenneth S. Suslick (born 1952) is the "Marvin T. Schmidt" Professor of Chemistry Emeritus at the University of Illinois at Urbana–Champaign. His area of focus is on the chemical and physical effects of ultrasound, sonochemistry, and sonoluminescence. In addition, he has worked in the fields of artificial and machine olfaction, electronic nose technology, chemical sensor arrays, and the use of colorimetric sensor arrays as an optoelectronic nose. Career. Ken Suslick received his B.S. from the California Institute of Technology in 1974, his Ph.D. from Stanford University in 1978, and came to the University of Illinois at  Urbana-Champaign immediately thereafter. Professor Suslick is a Fellow of the National Academy of Inventors, the American Chemical Society, the Royal Society of Chemistry, the Materials Research Society, the Acoustical Society of America, the American Physical Society, and the American Association for the Advancement of Science. Professor Suslick has mentored more than 75 Ph.D. students and 35 postdoctoral associates. He has published more than 427 scientific papers, edited four books, and holds more than 64 patents and patent applications. His papers have been cited more than 56,000 times and his h-index is 121 (i.e., 121 papers with 121 or  more citations), as of January, 2021. His six most cited papers are listed below. In addition to his academic research, Professor Suslick has had significant entrepreneurial experience. He was the lead consultant for Molecular Biosystems Inc. and part of the team that commercialized the first echo contrast agent for medical sonography, Albunex™, which became Optison™ by GE Healthcare. In addition, he was the founding consultant for VivoRx Pharmaceuticals and helped invent and commercialize Abraxane™, albumin microspheres with a paclitaxel core, which is the predominant current delivery system for taxol chemotherapy for breast cancer; VivoRx became Abraxis Bioscience , which was acquired by Celgene for $2.9 billion. He then co-founded ChemSensing and its successor companies, Specific Diagnostics, Inc., and iSense Systems in Mountain View, for the commercialization of the Suslick group's optoelectronic nose technology with particular focus on biomedical applications. Research interests. The Suslick Research Group at the University of Illinois at Urbana–Champaign is multi-disciplinary and has worked on three major research areas: (1) the chemical and physical effects of ultrasound (which includes nano-materials synthesis and sonoluminescence); (2) the mechanochemistry of inorganic solids (including shock wave energy dissipation by MOFs, i.e., metal-organic  framework solids); and (3) chemical sensing, molecular recognition, and artificial olfaction, which is a spinoff of earlier work on the bioinorganic and materials chemistry of metalloporphyrins. Of particular interest is the development of the optoelectronic nose, i.e., colorimetric sensor arrays for the detection of VOCs, toxic industrial chemicals, explosives, as well as diverse QA/QC applications for foods and beverages. Selected works (for a complete list of publication and with downloadable pdfs here). Overviews: Regarding sonochemistry: Regarding sonoluminescence: Regarding chemical sensing and electronic nose technology: Regarding mechanochemistry of inorganic solids and Metal-organic framework solids (MOFs): Kenneth S. Suslick Kenneth